At Siinovia, quality and regulatory compliance are fundamental to how we develop, license and supply medicines. We operate within established pharmaceutical regulatory frameworks, applying relevant MHRA, EMA and ICH requirements and guidance, together with applicable GMP and GDP principles.
Our quality approach extends across the product lifecycle and includes appropriate oversight of our manufacturing, development and supply partners. Through risk-based qualification, quality agreements, audits and ongoing monitoring, we work to maintain consistent standards across our supply network.
Patient safety remains central to our approach. Our processes support the identification, assessment and appropriate management of product quality and safety matters throughout the product lifecycle.
We promote clear accountability, continuous improvement and an organisation-wide commitment to quality – supporting the standards expected by patients, healthcare professionals, regulators and our partners.